Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection

J Am Coll Cardiol. 2021 Jan 5;77(1):104. doi: 10.1016/j.jacc.2020.08.090.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Heparin / adverse effects
  • Humans
  • SARS-CoV-2
  • ST Elevation Myocardial Infarction* / diagnosis
  • Thrombosis*

Substances

  • Heparin